Table 1:
Baseline clinical characteristics among survivals and non-survivals
| Parameters | All Patients (n=116) | Surviving (N=106) | Non-surviving (N=10) | P value |
|---|---|---|---|---|
| Clinical characteristics | ||||
| Age, years | 61.3 ± 13.5 | 60.0 ± 12.9 | 77.3 ± 9.2 | <0.0001 |
| Female, % | 32 | 29.5 | 60 | 0.07 |
| Whites, % | 92 | 93.8 | 80 | 0.12 |
| HTN, % | 52 | 49.1 | 80 | 0.09 |
| DM, % | 24 | 22.3 | 40. | 0.24 |
| Smoking, % | 62 | 62.2 | 60 | 1.00 |
| CHF, % | 5.1 | 5.4 | 0 | 1.00 |
| CAD, % | 18 | 16.1 | 40 | 0.08 |
| Meds | ||||
| ASA, % | 28 | 25.9 | 50 | 0.13 |
| Statin, % | 34 | 33 | 60 | 0.16 |
| BB, % | 24 | 21.4 | 40 | 0.23 |
| ACEi/ARB, % | 28 | 25.9 | 50 | 0.13 |
| Diuretics, % | 9 | 8.9 | 10 | 1.00 |
| Labs | ||||
| Peak Troponin, ng/ml | 104.9 ± 127.0 | 106.1 ± 131.6 | 105.5 ± 82.2 | 0.47 |
| Anterior STEMI on ECG, % | 38 | 40.5 | 20 | 0.31 |
| Echocardiogram | ||||
| LVEF, % | 50.0 ± 12.0 | 50.4±11.9 | 45.6 ± 12.4 | 0.24 |
| LVEF < 35%, % | 14.6 | 20.0 | 14.15 | 0.63 |
| EDWS, Kpa | 12.5 ± 6.5 | 12.3 ± 6.3 | 14.6 ± 9.1 | 0.34 |
| ESWS, Kpa | 60.9 ± 28.9 | 59.3 ± 27.7 | 80.0 ± 36.9 | 0.03 |
| LV EDV, ml | 92.9 ± 41.3 | 92.8 ± 40.7 | 93.2 ± 48.9 | 0.97 |
| LV ESV, ml | 47.9 ± 34.7 | 47.4 ± 35.16 | 54.2 ±30.7 | 0.55 |
| LV SV, ml | 44.9 ± 17.9 | 45.5 ± 17.2 | 39.0 ± 24.5 | 0.27 |
| Coronary Angiogram | ||||
| PCI of: | ||||
| LAD, % | 43 | 44.4 | 30 | 0.81 |
| LCx, % | 9 | 8.3 | 10 | |
| RCA, % | 44 | 42.6 | 60 | |
| 3 Vessel dis, % | 24 | 23.4 | 30 | 0.70 |
| >50% LM stenosis, % | 5.1 | 2.8 | 30 | 0.007 |
| LV EDP, mmHg | 21.9 ± 8.0 | 22.2 ± 7.9 | 19.5 ± 8.4 | 0.34 |
| LV SP, mmHg | 119.8 ± 17.5 | 118.9 ± 16.5 | 129.8 ± 25.5 | 0.06 |
| Outcomes | ||||
| Hospital LOS, hrs | 96.8 ± 137.2 | 96.4 ± 142 | 101.7 ± 46.7 | 0.15 |
| MACE, % | 17 | 16.5 | 30 | 0.37 |
HTN, hypertension; DM, diabetes mellitus; CHF, congestive heart failure; CKD, chronic kidney disease; STEMI, ST-elevation myocardial infarction; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; EDWS, end-diastolic wall stress; ESWS, end-systolic wall stress; LVEF, left ventricular ejection fraction; PCI, percutaneous intervention; LOS, length of stay; MACE, major adverse cardiac events. LV SV, LV stroke volume; LV EDV, LV end-diastolic volume; LVEDP, LV end-diastolic pressure; LVSP, LV systolic pressure.